biotech · CLDI
Calidi Biotherapeutics
Calidi Biotherapeutics patent portfolio — 7 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, USA
- Programs
- 0
- Drugs
- 0
- Patents
- 7
Calidi Biotherapeutics patents
7 pharmaceutical patents indexed for Calidi Biotherapeutics. 0 expire within 24 months.
Calidi Biotherapeutics has 7 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12036278
Smallpox vaccine for cancer treatment
granted -
US 11655455
Enhanced systems for cell-mediated oncolytic viral therapy
granted -
US 11607450
Smallpox vaccine for cancer treatment
granted -
US 11505782
Cell-based vehicles for potentiation of viral therapy
granted -
US 11285194
Combination immunotherapy approach for treatment of cancer
granted -
US 10857225
Smallpox vaccine for cancer treatment
granted -
US 10105436
Smallpox vaccine for cancer treatment
granted
Frequently asked questions
How many patents does Calidi Biotherapeutics have?
7 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Calidi Biotherapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.